Compile Data Set for Download or QSAR
Report error Found 534 Enz. Inhib. hit(s) with all data for entry = 12857
TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734140BDBM734140(3-(5-(furan-2-yl)pyridin-3-yl)phenyl octylcarbamat...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734155BDBM734155(3-(5-(1,3,4-oxadiazol-2-yl)pyridine-3-yl)phenyl oc...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734219BDBM734219(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-fluorop...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734074BDBM734074(3-(5-(furan-2-yl)pyridin-3-yl)phenyl octylcarbamat...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734154BDBM734154(3-(5-(1,3,4-oxadiazol-2-yl)134 pyridine-3-yl)pheny...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734250BDBM734250(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-4-hydrox...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734031BDBM734031(ethyl 5-(3-((tetradecylcarbamoyl)oxy)phenyl)nicoti...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734191BDBM734191(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-methoxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734287BDBM734287(3-(6-(1,3,4-oxadiazol-2-yl)pyrazin-2-yl)phenyl oct...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734237BDBM734237(3-(5-(1,3,4-thiadiazol-2-yl)pyridin-3-yl)-4-methox...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734036BDBM734036(methyl 5-(3-((heptylcarbamoyl)oxy)phenyl)nicotinat...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734100BDBM734100(3-(5-(oxazol-2-yl)pyridin-3-yl)phenyl octylcarbama...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734180BDBM734180(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-hydroxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734099BDBM734099(3-(5-(oxazol-2-yl)pyridin-3-yl)phenyl heptylcarbam...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734131BDBM734131(3-(5-(isoxazol-5-yl)pyridin-3-yl)phenyl octylcarba...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734243BDBM734243(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)phenyl oc...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734184BDBM734184(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734280BDBM734280(3-(4-(1,3,4-oxadiazol-2-yl)pyridin-2-yl)phenyl hep...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734135BDBM734135(3-(5-(isoxazol-5-yl) pyridin-3-yl)-4-methoxyphenyl...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734231BDBM734231(3-(5-(1,3,4-thiadiazol-2-yl)pyridin-3-yl)phenyl oc...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734198BDBM734198(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-methoxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734037BDBM734037(methyl 5-(3-((octylcarbamoyl)oxy)phenyl)nicotinate...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734181BDBM734181(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-hydroxy...)
Affinity DataIC50: 5.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734051BDBM734051(3-(5-(hydroxycarbamoyl)pyridin-3-yl)phenyl tetrade...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734156BDBM734156(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl dod...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734153BDBM734153(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl hex...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734161BDBM734161(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl cyc...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734158BDBM734158(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl (cy...)
Affinity DataIC50: 15nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734157BDBM734157(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl tet...)
Affinity DataIC50: 20nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734113BDBM734113(4-fluoro-3-(5-(oxazol-2-yl)pyridin-3-yl)phenyl cyc...)
Affinity DataIC50: 23.9nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734189BDBM734189(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 25.8nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734091BDBM734091(3-(5-(thiophen-2-yl)pyridin-3-yl)phenyl cyclohepty...)
Affinity DataIC50: 39.1nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734218BDBM734218(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-fluorop...)
Affinity DataIC50: 49.1nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734284BDBM734284(3-(4-(1,3,4-oxadiazol-2-yl)pyridin-2-yl)phenyl cyc...)
Affinity DataIC50: 50.5nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734188BDBM734188(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734059BDBM734059(3-(5-(trifluoromethyl)pyridin-3-yl)phenyl cyclopen...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734187BDBM734187(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734058BDBM734058(3-(5-(trifluoromethyl)pyridin-3-yl)phenyl (cyclohe...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734057BDBM734057(3-(5-(trifluoromethyl)pyridin-3-yl)phenyl octylcar...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734185BDBM734185(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-5-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734256BDBM734256(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-4-methox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734062BDBM734062(3-(5-(1H-pyrrol-2-yl)pyridin-3-yl)phenyl octylcarb...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734190BDBM734190(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-methoxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734253BDBM734253(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-4-hydrox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734244BDBM734244(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)phenyl (c...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734114BDBM734114(3-(5-(oxazol-2-yl)pyridin-3-yl)-4-(trifluoromethox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734242BDBM734242(3-(5-(1,3,4-thiadiazol-2-yl)pyridin-3-yl)-4-methox...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734183BDBM734183(3-(5-(1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-hydroxy...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734054BDBM734054(3-(5-cyanopyridin-3-yl)phenyl octylcarbamate | US2...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetFatty-acid amide hydrolase 1(Human)
Apogee Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 734246BDBM734246(3-(5-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)phenyl (n...)
Affinity DataIC50: 55nMAssay Description:The inhibitory effect of compounds of Formula (I-IV) on the activity of human recombinant FAAH was studied using a commercial inhibitor screening kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

Displayed 1 to 50 (of 534 total ) | Next | Last >>
Jump to: